CNSX:KBB Kaneh Bosm Biotechnology (KBB) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free KBB Stock Alerts Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.33 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Kaneh Bosm Biotechnology alerts: Email Address Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Kaneh Bosm BiotechnologyKaneh Bosm Biotechnology Inc., formerly Anexco Resources Ltd., operates in the cannabis sector. The Company focuses on the deployment of kiosks to ultimate retail locations, and is evaluating various gold and lithium mining assets for potential acquisition. The Company is focused on identifying, acquiring and developing projects with a focus on precious metals deposits. The Company entered into a purchase agreement with Alps Innovations Group Inc. for North and South American rights to an intelligent automated retail kiosk, the BioCanna ADM Automated Cannabis retail system, for the dispensing of cannabis and related products in both medical and commercial markets (the Agreement). BioCanna ADM system is an automated dispensing machine, which is a hybrid between a bank automatic teller machine (ATM), and an intelligent retail kiosk. It operates its engineering, procurement and construction (EPC) division, a full-service engineering, procurement and construction service.Read More Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here KBB Stock News HeadlinesMay 5, 2023 | finance.yahoo.comKelley Blue Book Names 2023 5-Year Cost to Own Award WinnersOctober 26, 2022 | finance.yahoo.comKelley Blue Book's 2022 Best Cars for Teens - The List Every Parent Needs in Today's Challenging Car MarketMarch 29, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. September 25, 2022 | finance.yahoo.comNASDAQ Biotechnology (^NBI)See More Headlines Receive KBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kaneh Bosm Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorN/A Industry N/A Sub-IndustryN/A Current SymbolCNSX:KBB CUSIPN/A CIKN/A WebN/A Phone+1-604-2831722FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMichael MartinzPresident, DirectorRudy de JongeChief Executive Officer, DirectorAnthony Jackson (Age 34)Chief Financial Officer Kent Ausburn Ph.D.Chief Operating Officer, DirectorMatthew Wyatt Lechtzier (Age 53)Director KBB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Kaneh Bosm Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other Kaneh Bosm Biotechnology investors own include Jubilee Metals Group (JLP), 156478 (DDD.L) (DDD), Clontarf Energy (CLON) and ADVFN (AFN). How do I buy shares of Kaneh Bosm Biotechnology? Shares of KBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:KBB) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaneh Bosm Biotechnology Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.